
Develop techniques to screen biotech prospects, ask the right questions, and evaluate pipelines and regulatory risks to profit from the growing healthcare and biotech markets.
This lecture contains links used in this course.
Explore the drug development process from preclinical research through phase 1–3 trials, FDA decisions, and the financial risks and opportunities for biotech investors.
Use the healthcare sector screener to filter biotech stocks by descriptive, fundamental, and technical criteria, including market capitalization, earnings, and insider and institutional ownership, to identify safer, on-market opportunities.
Explore healthcare market research for biotech stocks using IMX health databases on patient populations and drug prescriptions to identify indications and country trial potentials.
Examine how CROs and market researchers like Quintiles and Excel deliver end-to-end clinical development services, from consulting and regulatory support to trial execution and data solutions.
Analyze a downloaded clinical trials csv to interpret condition, phase, recruitment, interventions, sponsor, enrolments, study design, and key dates for biotech trading decisions.
Do you plan on trading biotech stocks?
Do you want to learn how to identify promising healthcare stocks?
Do you want to professionally read a company pipeline?
Do you want to know where to get all the relevant info for biotech/healthcare company evaluation?
Do you want to tailor your investment strategy towards a healthcare portfolio?
Those are just some of the question you will learn in this tutorial!
The biotech industry can be highly rewarding if you, as an investor, know how to read the signs. Healthcare is a highly relevant topic to all of us. In various stages of our lives we get costumers of healthcare companies. Ranging from simple over the counter (OTC) pain killers to high tech antibodies, biotech does all the development work to finally provide us with the medical support we need.
The whole drug market will reach 1 TRILLION USD of sales in the next years. It is a gigantic market, which is highly influencing our economy. So far it is mainly the sphere of investment funds, banks and insurances who have highly educated staff to properly read the signs.
It is a risky industry to invest in. Often times we see hit or miss events, with either huge stock price gains or losses. To protect yourself against clueless trading and the superiority of institutional traders, it is important to get proper training first.
Biotech training material and education for the private investor is hard to find. With this unique course you will learn the principles that lead the whole healthcare sector. If you understand how drug development works, you will be able to read the signs and make sound decisions.
If you want to earn more money with healthcare and biotech stocks, I would highly recommend to take this course. Understand the principles of healthcare first, so that you have the power to make your own decisions and not rely on external sources!
Martin